Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYCFX vs. FBIOX: which is better?

Bottom line

RYCFX vs FBIOX: the short answer

RYCFX (Biotechnology Fund) and FBIOX (Biotechnology Portfolio) are both mutual funds.

But FBIOX is far broader, holding 215 positions to 74 for RYCFX, so beyond the top names it adds exposure RYCFX doesn't have.

FBIOX is cheaper at 0.62% vs 2.38% — a difference of $176 a year per $10,000 invested.

Over five years, FBIOX returned +3.5% a year vs +3.0% for RYCFX (reporting dates differ).

Updated Nov 19, 2026

RYCFX vs FBIOX side by side

RYCFXFBIOX
TypeMutual fundMutual fund
Fund familyGuggenheimFidelity
CategoryTechnology SectorTechnology Sector
Expense ratio2.38%0.62%
Annual cost per $10k$238$62
10-yr cost on $10k (prospectus)$2,763$774
Max front load0%—
12b-1 fee1%0%
1-yr return+28.4%+36.4%
5-yr return (annualized)+3.0%+3.5%
10-yr return (annualized)+4.8%+6.9%
Best quarter+28.0%+33.6%
Worst quarter−22.7%−28.4%
Net assets (fund)$136.8M$5.3B
Number of holdings74215
Portfolio turnover75%45%
Returns as ofDec 31, 2025Apr 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYCFXFBIOXDifference
2025+29.4%+36.4%−7.0%
2024−1.7%+7.3%−9.0%
2023+5.0%+10.1%−5.1%
2022−13.9%−15.9%+1.9%
2021+0.8%−12.4%+13.2%
2020+20.9%+38.3%−17.5%
2019+23.8%+36.0%−12.2%
2018−9.9%−10.7%+0.8%
2017+28.4%+27.9%+0.6%
2016−20.3%−23.7%+3.4%

Source: Fund prospectus bar charts

Holdings overlap

13 of RYCFX's top 25 holdings also appear in FBIOX's top 25.

Shared top holdings
HoldingRYCFXFBIOX
Abbvie Inc8.17%9.22%
Amgen Inc5.05%6.53%
Gilead Sciences Inc4.49%4.82%
Revolution Medicines Inc2.48%2.02%
Alnylam Pharmaceuticals Inc2.36%2.93%
Moderna Inc2.15%1.28%
Biogen Inc2.13%1.26%
Natera Inc2.12%1.41%
Insmed Inc1.79%2.25%
Roivant Sciences Ltd1.66%1.13%
Argenx Se1.48%2.25%
Jazz Pharmaceuticals Plc1.42%1.84%
Bridgebio Pharma Inc1.38%0.89%

Source: SEC Form N-PORT

RYCFX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FBIOX top 10

  1. Krystal Biotech Inc — 10.58%
  2. Abbvie Inc — 9.22%
  3. Amgen Inc — 6.53%
  4. Gilead Sciences Inc — 4.82%
  5. Fidelity Revere Street Trust — 3.35%
  6. Alnylam Pharmaceuticals Inc — 2.93%
  7. Praxis Precision Medicines Inc. — 2.47%
  8. Insmed Inc — 2.25%
  9. Argenx Se — 2.25%
  10. Ascendis Pharma A/s — 2.04%

FAQ

What is the difference between RYCFX and FBIOX?
RYCFX (Biotechnology Fund) and FBIOX (Biotechnology Portfolio) are both mutual funds. But FBIOX is far broader, holding 215 positions to 74 for RYCFX, so beyond the top names it adds exposure RYCFX doesn't have.
Which is cheaper, RYCFX or FBIOX?
FBIOX has the lower expense ratio (0.62%).
Should I own both RYCFX and FBIOX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.